Enteral Glutamine in Neurologically-injured Patients
NCT00204971 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102
Last updated 2015-10-01
Summary
Nutrition is an important part of the recovery process after having a head injury so that subjects can gain strength and fight off infection. Liquid nutrition formulas are often given to patients through a tube that has been placed into the intestines for feeding when they are unable to eat on their own. Some reports suggest that nutrition with extra amounts of the amino acid called glutamine may decrease infections and hospital stay in severely injured patients.The purpose of this study is to evaluate if giving extra amounts of an amino acid called glutamine with liquid nutrition formulas will decrease the risk of infection and length of stay in the intensive care unit after having a head injury.
Conditions
- Neurologic Injury
- Traumatic Brain Injury
Interventions
- DIETARY_SUPPLEMENT
-
Enteral glutamine powder
nutritional supplement
- OTHER
-
placebo
placebo control
Sponsors & Collaborators
-
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Gordon S Sacks, PharmD · University of Wisconsin, Madison
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Primary Completion
- 2008-01-31
- Completion
- 2008-01-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis
NCT04990219 ·Status: TERMINATED ·Phase: PHASE1
-
A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.
NCT00605930 ·Status: COMPLETED ·Phase: NA
-
Brain Mechanisms Underlying the Effect of the Motilin Receptor Agonist Erythromycin on Hunger in Normal Weight Subjects
NCT02212821 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Magnesium Sulphate on Neostigmine
NCT03020706 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess NEU-627 in Healthy Participants
NCT06900751 ·Status: COMPLETED ·Phase: PHASE1
-
Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)
NCT01382901 ·Status: COMPLETED ·Phase: PHASE2
-
EIMD Mechanisms Causing Force Loss
NCT02125643 ·Status: TERMINATED ·Phase: PHASE1
-
Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients
NCT02146534 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerability of Beta Hydroxybutyrate Ester in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT04820478 ·Status: COMPLETED ·Phase: NA
-
Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia
NCT02363075 ·Status: UNKNOWN ·Phase: PHASE3
-
Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
NCT02960217 ·Status: TERMINATED ·Phase: PHASE3
-
A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome
NCT01549847 ·Status: WITHDRAWN ·Phase: PHASE3
-
Electromyography in Patients on Chronic Pyridostigmine Therapy
NCT02364180 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT04944784 ·Status: TERMINATED ·Phase: PHASE3
-
A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
NCT06673056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Memantine for Enhanced Stroke Recovery
NCT02144584 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Acetyl-leucine in Post-stroke Ataxia
NCT07275749 ·Status: RECRUITING ·Phase: PHASE3
-
Trial of Amivita in Amyotrophic Lateral Sclerosis
NCT03103815 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial Nuedexta in Subjects With ALS
NCT01806857 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
NCT01281631 ·Status: COMPLETED ·Phase: PHASE2
-
Valproate and Levocarnitine in Children With Spinal Muscular Atrophy
NCT01671384 ·Status: UNKNOWN ·Phase: PHASE3
-
Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS
NCT02397057 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis
NCT02655614 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans
NCT03754842 ·Status: COMPLETED ·Phase: NA
-
Glucocorticosteroid Treatment in Acute Unilateral Vestibulopathy (Vestibular Neuronitis)
NCT05024448 ·Status: COMPLETED ·Phase: PHASE4